Aehr Test Systems (NASDAQ:AEHR) Director Howard Slayen Sells 5,700 Shares of Stock

Aehr Test Systems (NASDAQ:AEHR) Director Howard Slayen sold 5,700 shares of the firm’s stock in a transaction on Friday, August 14th. The stock was sold at an average price of $133.03, for a total value of $758,271.00. Following the transaction, the director owned 140,667 shares in the company, valued at approximately $18,712,931.01. This trade represents a 3.89% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Aehr Test Systems Stock Performance

NASDAQ:AEHR opened at $134.06 on Friday. The company has a market cap of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10. Aehr Test Systems has a fifty-two week low of $16.38 and a fifty-two week high of $147.40. The stock has a fifty day moving average price of $92.83 and a 200-day moving average price of $71.45.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the stock. Wall Street Zen raised shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a research note on Saturday, July 18th. Jefferies Financial Group started coverage on Aehr Test Systems in a research note on Thursday. They issued a “buy” rating and a $175.00 price objective for the company. Freedom Capital upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a report on Thursday, July 16th. Weiss Ratings lowered Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research report on Wednesday, July 29th. Finally, Lake Street Capital reiterated a “buy” rating and issued a $110.00 target price on shares of Aehr Test Systems in a report on Wednesday, July 15th. Three research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $136.67.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Advocate Investing Services LLC bought a new position in shares of Aehr Test Systems during the 2nd quarter valued at approximately $26,000. Compagnie Lombard Odier SCmA bought a new stake in shares of Aehr Test Systems in the second quarter valued at $34,000. KBC Group NV purchased a new position in shares of Aehr Test Systems during the 1st quarter valued at $30,000. Sunbelt Securities Inc. bought a new position in shares of Aehr Test Systems during the 3rd quarter worth $27,000. Finally, Tema ETFs LLC purchased a new stake in Aehr Test Systems during the second quarter valued at about $89,000. Institutional investors own 69.69% of the company’s stock.

Key Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.